ClassID:

96692

C07K5/06086 - CPC Classification

Classification description:

Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being basic

Sub-classes:
Recent Application in this class:
#1
20260091126
2026-04-02

AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY

#2
20260022128
2026-01-22

ANTI-C-MET ANTIBODY DRUG CONJUGATES

#3
20250353814
2025-11-20

NON-PEPTIDIC CELL-PENETRATING MOTIFS

#4
20250122238
2025-04-17

CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE

#5
20250109167
2025-04-03

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

#6
20250051389
2025-02-13

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#7
20250002530
2025-01-02

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#8
20240425814
2024-12-26

SALTS OF DIPEPTIDES AND THEIR USES IN CELL CULTURE

#9
20240398966
2024-12-05

CONJUGATES AND METHODS OF USING THE SAME

#10
20240392319
2024-11-28

TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME

#11
20240199687
2024-06-20

SUBSTITUTION OF HISTIDINE WITH 2-THIOHISTIDINE IN BIOACTIVE PEPTIDES

#12
20240101509
2024-03-28

NON-PEPTIDIC CELL-PENETRATING MOTIFS

#13
20240065990
2024-02-29

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#14
20240025945
2024-01-25

PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING

#15
20230372519
2023-11-23

ANTI-C-MET ANTIBODY DRUG CONJUGATES

#16
20230203093
2023-06-29

Crystalline dipeptides useful in the synthesis of elamipretide

#17
20230029187
2023-01-26

Modulators of programmed death-ligand-1 and/or programmed death-ligand-2

#18
20220411468
2022-12-29

Peptide macrocycles against

#19
20220378935
2022-12-01

Anti-c-Met antibody drug conjugates

#20
20220160813
2022-05-26

Inhibitors for proliferating cell nuclear antigen and uses

#21
20220090141
2022-03-24

Transfection complexes and methods of using the same

#22
20220009963
2022-01-13

TRANSITION METAL CHELATING BEADS

#23
20210386693
2021-12-16

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#24
20210292274
2021-09-23

Crystalline dipeptides useful in the synthesis of elamipretide

#25
20210261500
2021-08-26

Non-peptidic cell-penetrating motifs

#26
20210162057
2021-06-03

Conjugates and methods of using the same

#27
20210130402
2021-05-06

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#28
20210040149
2021-02-11

Aromatic-cationic peptides and uses of same

#29
20210040039
2021-02-11

NMDA ANTAGONIST PRODRUGS

#30
20200299327
2020-09-24

PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING

#31
20200283476
2020-09-10

Crystalline dipeptides useful in the synthesis of elamipretide

#32
20200253897
2020-08-13

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#33
20200009086
2020-01-09

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#34
20190275101
2019-09-12

Structure of GII.4 norovirus protease—design of broad-spectrum protease inhibitors

#35
20190202861
2019-07-04

N-carboxyanhydride-based-scale synthesis of elamipretide

#36
20190152914
2019-05-23

NMDA antagonist prodrugs

#37
20190127420
2019-05-02

Dipeptide analogs as TGF-beta inhibitors

#38
20190127419
2019-05-02

Neuropeptide S receptor (NPSR) agonists

#39
20190106458
2019-04-11

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#40
20190023738
2019-01-24

THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF

#41
20180371016
2018-12-27

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

#42
20180362579
2018-12-20

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#43
20180362578
2018-12-20

Peptide macrocycles against Acinetobacter baumannii

#44
20180360905
2018-12-20

Inhibitors for proliferating cell nuclear antigen and uses

#45
20180340188
2018-11-29

Transfection complexes and methods of using the same

#46
20180305404
2018-10-25

NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE

#47
20180236112
2018-08-23

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

#48
20180170961
2018-06-21

Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient

#49
20180147250
2018-05-31

Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods

#50
20180051302
2018-02-22

Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof

#51
20180037550
2018-02-08

NMDA antagonist prodrugs

#52
20180002375
2018-01-04

Protease-activated contrast agents for in vivo imaging

#53
20170267718
2017-09-21

Tripeptide compound, preparation method therefor, and application thereof

#54
20170260231
2017-09-14

Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof

#55
20170224759
2017-08-10

Compositions and methods for treating colorectal cancer

#56
20170204138
2017-07-20

Antibacterial agents

#57
20170190737
2017-07-06

Macrocyclic inhibitors of flaviviridae viruses

#58
20170183378
2017-06-29

Trapping reagents for reactive metabolites screening

#59
20170152289
2017-06-01

Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide

#60
20170129920
2017-05-11

Process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide

#61
20170121366
2017-05-04

Dipeptides as inhibitors of human immunoproteasomes

#62
20170096449
2017-04-06

Compositions and Methods Relating to Ionic Salts of Peptides

#63
20170095430
2017-04-06

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#64
20170008922
2017-01-12

Branched chain-containing aromatic compound

#65
20160340387
2016-11-24

Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide

#66
20160207915
2016-07-21

Prodrug derivatives of substituted triazolopyridines

#67
20160159777
2016-06-09

Crosslinking reagents, methods, and compositions for studying protein-protein interactions

#68
20160082106
2016-03-24

Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound

#69
20160031934
2016-02-04

Dipeptide and tripeptide epoxy ketone protease inhibitors

#70
20160002293
2016-01-07

Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation

#71
20150353601
2015-12-10

Compounds for enzyme inhibition

#72
20150344521
2015-12-03

Macrocyclic inhibitors of flaviviridae viruses

#73
20150337009
2015-11-26

Toll-like receptor 2-agonistic lipopeptides, and method of making the same

#74
20150315129
2015-11-05

Processes for forming amide bonds and compositions related thereto

#75
20150299250
2015-10-22

MACROCYCLIC COMPOUNDS AND USES THEREOF

#76
20150224208
2015-08-13

Prodrugs for selective anticancer therapy

#77
20150175662
2015-06-25

Peptides and use thereof

#78
20150175654
2015-06-25

Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient

#79
20150132440
2015-05-14

DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES

#80
20150119330
2015-04-30

Substrates and inhibitors of prolyl oligopeptidase and methods of use

#81
20150111828
2015-04-23

Dipeptide mimetics of NGF and BDNF neurotrophins

#82
20150087578
2015-03-26

Inflammation inhibiting compounds

#83
20150080291
2015-03-19

Short antimicrobial lipopeptides

#84
20150065437
2015-03-05

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#85
20150051160
2015-02-19

Tyrosine based linkers for the releasable connection of peptides

#86
20150045282
2015-02-12

Compositions containing delta-9-THC-amino acid esters and process of preparation

#87
20140220122
2014-08-07

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#88
20140206879
2014-07-24

Dipeptoid prodrugs and their use

#89
20140113868
2014-04-24

Peptide analogues with an excellent moisturizing effect and use thereof

#90
20140094567
2014-04-03

Diketopiperazine forming dipeptidyl linker

#91
20130059799
2013-03-07

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#92
20130053303
2013-02-28

Compounds for enzyme inhibition

#93
20130041008
2013-02-14

Compounds for enzyme inhibition

#94
20130035297
2013-02-07

Compounds for enzyme inhibition

#95
20130023475
2013-01-24

C-Met receptor regulation by angiotensin IV (AT4) receptor ligands

#96
20130022588
2013-01-24

Stable formulations of a hyaluronan-degrading enzyme

#97
20130011378
2013-01-10

Stable formulations of a hyaluronan-degrading enzyme

#98
20120322978
2012-12-20

CROSSLINKING REAGENTS, METHODS, AND COMPOSITIONS FOR STUDYING PROTEIN-PROTEIN INTERACTIONS

#99
20120288940
2012-11-15

Dipeptide acetylene conjugates and a method for photocleavage of double strand DNA by dipeptide acetylene conjugates

#100
20120252866
2012-10-04

Age inhibitors

#101
20120251459
2012-10-04

Specific inhibitors and active site probes for legumain

#102
20120225913
2012-09-06

Trypsin-like serine protease inhibitors, and their preparation and use

#103
20120214732
2012-08-23

Inhibitors of the trypsin-like site of the proteasome and methods of use thereof

#104
20120165276
2012-06-28

Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof

#105
20120108520
2012-05-03

Method of treating tumors

#106
20120108499
2012-05-03

PEPTOID COMPOUNDS

#107
20120107902
2012-05-03

Processes for forming amide bonds and compositions related thereto

#108
20120088762
2012-04-12

Compounds for enzyme inhibition

#109
20120059149
2012-03-08

Branched chain-containing aromatic compound

#110
20120045462
2012-02-23

Inflammation inhibiting compounds

#111
20120035096
2012-02-09

AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION

#112
20110312895
2011-12-22

DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS

#113
20110312875
2011-12-22

Peptidic compounds

#114
20110294719
2011-12-01

Dipeptoid prodrugs and the use thereof

#115
20110294718
2011-12-01

Dipeptoid prodrugs and the use thereof

#116
20110250153
2011-10-13

Oligomeric biosurfactants in dermatocosmetic compositions

#117
20110201559
2011-08-18

Optically pure compounds for improved therapeutic efficiency

#118
20110077412
2011-03-31

Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline

#119
20110046226
2011-02-24

Pharmaceutical compositions for prevention of overdose or abuse

#120
20110039849
2011-02-17

5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection

#121
20100291672
2010-11-18

Reagent for introduction of protein or gene

#122
20100280412
2010-11-04

Anticoagulation of human blood ex vivo

#123
20100267621
2010-10-21

Antimicrobial compounds and formulations

#124
20100239551
2010-09-23

COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS

#125
20100197609
2010-08-05

Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs

#126
20100167995
2010-07-01

PEPTOID COMPOUNDS

#127
20100160213
2010-06-24

Antimicrobial and anticancer lipopeptides

#128
20100152098
2010-06-17

Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof

#129
20100144649
2010-06-10

Compounds for enzyme inhibition

#130
20100144648
2010-06-10

Compounds for enzyme inhibition

#131
20100113770
2010-05-06

O-SUBSTITUTED HYDROXYARYL DERIVATIVES

#132
20100093973
2010-04-15

POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR

#133
20100056458
2010-03-04

Peptides Inhibiting Angiotensin-Converting Enzyme

#134
20100022781
2010-01-28

Trypsin-like serine protease inhibitors, and their preparation and use

#135
20090299036
2009-12-03

AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION

#136
20090286763
2009-11-19

AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF

#137
20090221684
2009-09-03

Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof

#138
20090209472
2009-08-20

Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents

#139
20090197315
2009-08-06

Fullerene-based amino acids

#140
20090175785
2009-07-09

Self-assembled Fmoc-ff hydrogels

#141
20090149401
2009-06-11

Amide and peptide derivatives of tetraalkylenepentamines as transfection agents

#142
20090133747
2009-05-28

COMPOUND HAVING PHOTOSENSITIZATION ACTIVITY, PHOTOELECTRODE, AND PHOTOSENSITIZATION-TYPE SOLAR CELL

#143
20090131478
2009-05-21

Growth hormone secretagogues

#144
20090117185
2009-05-07

2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa

#145
20090036653
2009-02-05

Methods for the directed expansion of epitopes for use as antibody ligands

#146
20090029926
2009-01-29

Lys-Thr dipeptides and their use

#147
20090012306
2009-01-08

Cationic amino acid type lipid

#148
20080318957
2008-12-25

POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

#149
20080300287
2008-12-04

Peptidic compounds

#150
20080300191
2008-12-04

Protease inhibitors for coronaviruses and SARS-CoV and the use thereof

#151
20080293634
2008-11-27

C-Met receptor regulation by angiotensin IV (AT) receptor ligands

#152
20080249030
2008-10-09

Age Inhibitors

#153
20080207874
2008-08-28

Peptide antibiotics and methods for making same

#154
20080200511
2008-08-21

Amino acid derivatives and pharmaceutical uses thereof

#155
20080176901
2008-07-24

COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS

#156
20080171698
2008-07-17

Anti-hypertensive molecules and process for preparation thereof

#157
20080146642
2008-06-19

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#158
20080146504
2008-06-19

Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability

#159
20070293465
2007-12-20

Compounds for enzyme inhibition

#160
20070129313
2007-06-07

Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)

#161
20070111927
2007-05-17

Peptoid compounds

#162
20070093426
2007-04-26

Histone H2A peptide derivatives and uses thereof

#163
20070072808
2007-03-29

Antimicrobial and anticancer lipopeptides

#164
20070037863
2007-02-15

Dipeptide phenyl ethers

#165
20060241055
2006-10-26

Peptides promoting cell adherence, growth and secretion

#166
20060194947
2006-08-31

Peptide gap junction modulators

#167
20060194259
2006-08-31

Method for isolating an allosteric effector of a receptor

#168
20060183691
2006-08-17

Anti-hypertensive molecules and process for preparation thereof

#169
20060166893
2006-07-27

2-hydroxytetrahydrofuran derivatives and use thereof as medicaments

#170
20060100160
2006-05-11

Amino acid derived prodrugs of propofol, compositions and uses thereof

#171
20060094718
2006-05-04

O-substituted hydroxyaryl derivatives

#172
20060068457
2006-03-30

Substrates for TAFI (A)

#173
20060014697
2006-01-19

Pharmaceutical compositions for prevention of overdose or abuse

#174
20060004185
2006-01-05

Peptide antibiotics and peptide intermediates for their prepartion

#175
20060003944
2006-01-05

Bacterial efflux pump inhibitors and methods of treating bacterial infections

#176
20050222045
2005-10-06

Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments

#177
20050221368
2005-10-06

Methods for identifying RNA binding compounds

#178
20050215484
2005-09-29

Di-, tri-, and tetra-peptides having antiangiogenic activity

#179
20050119190
2005-06-02

Inhibitors of the blood-clotting factor xa, production thereof and use of the same

#180
20050112185
2005-05-26

Positively charged lipid and liposome with the lipid

#181
20050089493
2005-04-28

Novel compounds

#182
20050075293
2005-04-07

Dipeptide phenyl ethers

#183
20050065090
2005-03-24

Dermopharmaceutically and cosmetically active oligopeptides

#184
20050043509
2005-02-24

Peptoid compounds

#185
20050032709
2005-02-10

Anti-hypertensive molecules and process for preparation thereof

#186
20050009755
2005-01-13

Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient

#187
20050004100
2005-01-06

ACE inhibitor derivatives

#188
15618875
2018-03-20

Composition having anti-oxidant, anti-aging, and autophagy activities and uses thereof